| Authors: |
Goyal L; Department of Medicine, Stanford University School of Medicine, & the Stanford Cancer Center, Palo Alto, CA, USA., Meric-Bernstam F; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hollebecque A; Drug Development Department, Gustave Roussy, Villejuif, France., Valle JW; Cholangiocarcinoma Foundation, Herriman, UT, USA.; Division of Cancer Sciences, University of Manchester, Manchester, UK., Morizane C; National Cancer Center Hospital, Tokyo, Japan., Karasic TB; Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Abrams TA; Mass General Cancer Center, Harvard Medical School, & Dana-Farber Cancer Institute, Boston, MA, USA., Furuse J; Kanagawa Cancer Center, Yokohama, Japan., Kelley RK; University of California, San Francisco, San Francisco, CA, USA., Cassier PA; Centre Léon Bérard, Lyon, France., Klümpen HJ; Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Chang HM; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Chen LT; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Tabernero J; Vall d'Hebron Hospital Campus & Vall d'Hebron Institute of Oncology, University of Vic-Central University of Catalonia, Baselga Oncologic Institute, Hospital Quiron, Barcelona, Spain., Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea., Mahipal A; Mayo Clinic, Rochester, MN, USA., Moehler M; University Medical Center of Johannes Gutenberg University, Mainz, Germany., Komatsu Y; Hokkaido University Hospital Cancer Center, Sapporo, Japan., Ahn DH; Mayo Clinic, Phoenix, AZ, USA., Epstein RS; Epstein Health, Woodcliff Lake, NJ, USA., Halim AB; Taiho Oncology, Inc., Princeton, NJ, USA., Wacheck V; Taiho Oncology, Inc., Princeton, NJ, USA., He Y; Taiho Oncology, Inc., Princeton, NJ, USA., Liu M; Taiho Oncology, Inc., Princeton, NJ, USA., Benhadji KA; Taiho Oncology, Inc., Princeton, NJ, USA., Bridgewater JA; University College London Cancer Institute, London, UK. |
